Mortality outcomes of patients with chronic kidney disease and chronic obstructive pulmonary disease

American Journal of Nephrology

Volumn 43, Issue 1, 2016, Pages 39-46

  Navaneethan, Sankar D ^a,b   Schold, Jesse D ^c   Huang, Haiquan ^a,d   Nakhoul, Georges ^c   Jolly, Stacey E ^c   Arrigain, Susana ^c   Dweik, Raed A ^c   Nally, Joseph V ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d SOUTHEAST UNIVERSITY   (China)

Author keywords

Cause specific death; Chronic obstructive pulmonary disease; Death and kidney disease; Lung disease

Indexed keywords

BRONCHODILATING AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; SMOKING; ADVERSE EFFECTS; AGE; AGED; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY DISEASE; FEMALE; FOLLOW UP; HEART FAILURE; MALE; MIDDLE AGED; OHIO; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OHIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING;

EID: 84958756475     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000444422     Document Type: Article

References (31)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370: 765-773.
2. Agarwal S, Rokadia H, Senn T, Menon V. Burden of cardiovascular disease in chronic obstructive pulmonary disease. Am J Prev Med. 2014; 47: 105-114.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
4. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012; 7: 1938-1946.
5. van Gestel YR, Chonchol M, Hoeks SE, Welten GM, Stam H, Mertens FW, et al. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant. 2009; 24: 2763-2767.
6. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V, et al. Chronic renal failure: a neglected comorbidity of COPD. Chest. 2010; 137: 831-837.
7. Chandra D, Stamm JA, Palevsky PM, Leader JK, Fuhrman CR, Zhang Y, et al. The relationship between pulmonary emphysema and kidney function in smokers. Chest. 2012; 142: 655-662.
8. Funakoshi Y, Omori H, Mihara S, Onoue A, Ogata Y, Aizawa H, et al. C-reactive protein levels, airflow obstruction, and chronic kidney disease. Environ Health Prev Med. 2012; 17: 18-26.
9. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, et al. Development and validation of an electronic health recordbased chronic kidney disease registry. Clin J Am Soc Nephrol. 2011; 6: 40-49.
10. Ford ES. Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and allcause mortality among US adults with obstructive lung function. Chest. 2015; 147: 56-67.
11. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015; 148: 971-985.
12. Abramson MJ, Schattner RL, Sulaiman ND, Del Colle EA, Aroni R, Thien F. Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J. 2012; 21: 167-173.
13. Afonso AS, Verhamme KM, Sturkenboom MC, Brusselle GG. COPD in the general population: prevalence, incidence and survival. Respir Med. 2011; 105: 1872-1884.
14. Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT study, Norway. Thorax. 2013; 68: 914-921.
15. Miniati M, Monti S, Pavlickova I, Bottai M. Survival in COPD: impact of lung dysfunction and comorbidities. Medicine (Baltimore). 2014; 93: e76.
16. Plywaczewski R, Maciejewski J, Bednarek M, Zieliński J, Gorecka D, Śliwiński P. Causes of deaths in COPD patients in primary care setting - A 6-year follow-up. Pneumonol Alergol Pol. 2015; 83: 193-202.
17. Lahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015; 36: 1754-1761.
18. Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang IK, et al. Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study. Medicine (Baltimore). 2014; 93: e174.
19. Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1487-1493.
20. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008; 359: 2355-2365.
21. McDonald HI, Thomas SL, Millett ER, Nitsch D. CKD and the risk of acute, communityacquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records. Am J Kidney Dis. 2015; 66: 60-68.
22. Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, et al. Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol. 2015; pii: ASN.2014111111.
23. Loprinzi PD, Walker JF, Lee H. Association between physical activity and inflammatory markers among U.S. adults with chronic obstructive pulmonary disease. Am J Health Promot. 2014; 29: 81-88.
24. Magnussen H, Watz H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc. 2009; 6: 648-651.
25. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, et al. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013; 8: 945-952.
26. Mannino DM, Higuchi K, Yu TC, Zhou H, Li Y, Tian H, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015; 148: 138-150.
27. Quint JK, Mullerova H, DiSantostefano RL, Forbes H, Eaton S, Hurst JR, et al. Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD). BMJ Open. 2014; 4: e005540.
28. Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax. 2015; 70: 888-895.
29. Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, et al. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res. 2011; 11: 37.
30. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV Jr. Cause-specific deaths in nondialysis-dependent CKD. J Am Soc Nephrol. 2015; 26: 2512-2520.
31. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015; 70: 683-691.